These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8342398)

  • 1. Georges Brohee Prize. Oestrogen-progesterone, a new therapy of bleeding gastrointestinal vascular malformations.
    Van Cutsem E
    Acta Gastroenterol Belg; 1993; 56(1):2-10. PubMed ID: 8342398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone.
    van Cutsem E; Rutgeerts P; Vantrappen G
    Lancet; 1990 Apr; 335(8695):953-5. PubMed ID: 1970032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.
    Proctor DD; Henderson KJ; Dziura JD; White RI
    J Clin Gastroenterol; 2008 Jul; 42(6):756-7. PubMed ID: 18496387
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study.
    Tran A; Villeneuve JP; Bilodeau M; Willems B; Marleau D; Fenyves D; Parent R; Pomier-Layrargues G
    Am J Gastroenterol; 1999 Oct; 94(10):2909-11. PubMed ID: 10520843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric antral vascular ectasia: maintenance treatment with oestrogen-progesterone.
    Moss SF; Ghosh P; Thomas DM; Jackson JE; Calam J
    Gut; 1992 May; 33(5):715-7. PubMed ID: 1612493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe gastrointestinal hemorrhage secondary to diffuse angiodysplasia: efficacy of estrogen-progesterone treatment].
    Cacoub P; Sbaï A; Benhamou Y; Godeau P; Piette JC
    Presse Med; 2000 Jan; 29(3):139-41. PubMed ID: 10686963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy for gastrointestinal angiodysplasia.
    Hodgson H
    Lancet; 2002 May; 359(9318):1630-1. PubMed ID: 12020519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Successful treatment of recurrent lower gastrointestinal hemorrhage in intestinal angiodysplasia with an estrogen-progesterone combination].
    Schoenemann J
    Z Gastroenterol; 1993 Nov; 31(11):690. PubMed ID: 8291285
    [No Abstract]   [Full Text] [Related]  

  • 9. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure. An uncontrolled trial.
    Bronner MH; Pate MB; Cunningham JT; Marsh WH
    Ann Intern Med; 1986 Sep; 105(3):371-4. PubMed ID: 3488703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.
    Longacre AV; Gross CP; Gallitelli M; Henderson KJ; White RI; Proctor DD
    Am J Gastroenterol; 2003 Jan; 98(1):59-65. PubMed ID: 12526937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of estrogens and progestational hormones in persistent hemorrhagic recurrences in digestive angiodysplasia after discontinuation of hormone therapy].
    Li V
    Gastroenterol Clin Biol; 1993; 17(12):978-9. PubMed ID: 8125238
    [No Abstract]   [Full Text] [Related]  

  • 12. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia.
    Kjeldsen AD; Kjeldsen J
    Am J Gastroenterol; 2000 Feb; 95(2):415-8. PubMed ID: 10685743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic transfusion-requiring watermelon stomach with oral contraceptives].
    Knudsen HE; Ott P
    Ugeskr Laeger; 2002 Jun; 164(25):3364-6. PubMed ID: 12107954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rendu-Osler disease: treatment with oestrogen/progestagen versus octreotide.
    Jeanneret S; Regazzoni L; Favrat B
    BMJ Case Rep; 2011 Feb; 2011():. PubMed ID: 22707551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bleeding arteriovenous malformations with oral contraceptives: safe sex?
    Schubert ML
    Gastroenterology; 1991 Jul; 101(1):263-4. PubMed ID: 2044914
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful therapy with bevacizumab in a case of hereditary hemorrhagic telangiectasia.
    Kochanowski J; Sobieszczańska M; Tubek S; Żurek M; Pawełczak J
    Hum Vaccin Immunother; 2015; 11(3):680-1. PubMed ID: 25839219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-progesterone treatment of Osler-Weber-Rendu disease.
    Van Cutsem E; Rutgeerts P; Geboes K; Van Gompel F; Vantrappen G
    J Clin Gastroenterol; 1988 Dec; 10(6):676-9. PubMed ID: 3265945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen/progesterone treatment of diffuse antral vascular ectasia.
    Manning RJ
    Am J Gastroenterol; 1995 Jan; 90(1):154-6. PubMed ID: 7801925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of push enteroscopy on transfusion requirements and quality of life in patients with unexplained gastrointestinal bleeding.
    Vakil N; Huilgol V; Khan I
    Am J Gastroenterol; 1997 Mar; 92(3):425-8. PubMed ID: 9068462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.